Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

Association of Estimated Pulse Wave Velocity With Survival: A Secondary Analysis of SPRINT.

Vlachopoulos C, Terentes-Printzios D, Laurent S, Nilsson PM, Protogerou AD, Aznaouridis K, Xaplanteris P, Koutagiar I, Tomiyama H, Yamashina A, Sfikakis PP, Tousoulis D.

JAMA Netw Open. 2019 Oct 2;2(10):e1912831. doi: 10.1001/jamanetworkopen.2019.12831.

PMID:
31596491
2.

Joint microwave radiometry for inflammatory arthritis assessment.

Laskari K, Pentazos G, Pitsilka D, Raftakis J, Konstantonis G, Toutouzas K, Siores E, Tektonidou M, Sfikakis PP.

Rheumatology (Oxford). 2019 Sep 5. pii: kez373. doi: 10.1093/rheumatology/kez373. [Epub ahead of print]

PMID:
31504966
3.

Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.

Vlachogiannis NI, Gatsiou A, Silvestris DA, Stamatelopoulos K, Tektonidou MG, Gallo A, Sfikakis PP, Stellos K.

J Autoimmun. 2019 Sep 4:102329. doi: 10.1016/j.jaut.2019.102329. [Epub ahead of print]

4.

CMR feature tracking in cardiac asymptomatic systemic sclerosis: Clinical implications.

Bratis K, Lindholm A, Hesselstrand R, Arheden H, Karabela G, Stavropoulos E, Katsifis G, Kolovou G, Kitas GD, Sfikakis PP, Koutsogeorgopoulou L, Mavrogeni S, Ostenfeld E.

PLoS One. 2019 Aug 21;14(8):e0221021. doi: 10.1371/journal.pone.0221021. eCollection 2019.

5.

Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift.

Chatzidionysiou K, Sfikakis PP.

RMD Open. 2019 Jul 27;5(2):e000993. doi: 10.1136/rmdopen-2019-000993. eCollection 2019. Review.

6.

Silent Myocardial Perfusion Abnormalities Detected by Stress Cardiovascular Magnetic Resonance in Antiphospholipid Syndrome: A Case-Control Study.

Mavrogeni SI, Markousis-Mavrogenis G, Karapanagiotou O, Toutouzas K, Argyriou P, Velitsista S, Kanoupakis G, Apostolou D, Hautemann D, Sfikakis PP, Tektonidou MG.

J Clin Med. 2019 Jul 23;8(7). pii: E1084. doi: 10.3390/jcm8071084.

7.

Mechanics of early ventricular impairment in systemic sclerosis and the effects of peripheral arterial haemodynamics.

Tountas C, Protogerou AD, Bournia VK, Panopoulos S, Konstantonis G, Tektonidou MG, Gournizakis A, Beldekos D, Sfikakis PP.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):57-62. Epub 2019 Jun 4.

8.

A Special Report on Changing Trends in Preventive Stroke/Cardiovascular Risk Assessment Via B-Mode Ultrasonography.

Jamthikar A, Gupta D, Khanna NN, Araki T, Saba L, Nicolaides A, Sharma A, Omerzu T, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Protogerou A, Sfikakis PP, Kitas GD, Viswanathan V, Pareek G, Miner M, Suri JS.

Curr Atheroscler Rep. 2019 May 1;21(7):25. doi: 10.1007/s11883-019-0788-4. Review.

PMID:
31041615
9.

The present and future of deep learning in radiology.

Saba L, Biswas M, Kuppili V, Cuadrado Godia E, Suri HS, Edla DR, Omerzu T, Laird JR, Khanna NN, Mavrogeni S, Protogerou A, Sfikakis PP, Viswanathan V, Kitas GD, Nicolaides A, Gupta A, Suri JS.

Eur J Radiol. 2019 May;114:14-24. doi: 10.1016/j.ejrad.2019.02.038. Epub 2019 Mar 2. Review.

PMID:
31005165
10.

DNA damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis.

Souliotis VL, Vlachogiannis NI, Pappa M, Argyriou A, Sfikakis PP.

Clin Immunol. 2019 Jun;203:28-36. doi: 10.1016/j.clim.2019.03.009. Epub 2019 Mar 28.

PMID:
30930144
11.

A clinical score for prediction of elevated aortic stiffness: derivation and validation in 3943 hypertensive patients.

Xaplanteris P, Vlachopoulos C, Protogerou AD, Aznaouridis K, Terentes-Printzios D, Argyris AA, Tentolouris N, Sfikakis PP, Tousoulis D.

J Hypertens. 2019 Feb;37(2):339-346. doi: 10.1097/HJH.0000000000001904.

PMID:
30645208
12.

Performance evaluation of 10-year ultrasound image-based stroke/cardiovascular (CV) risk calculator by comparing against ten conventional CV risk calculators: A diabetic study.

Khanna NN, Jamthikar AD, Gupta D, Nicolaides A, Araki T, Saba L, Cuadrado-Godia E, Sharma A, Omerzu T, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Protogerou A, Sfikakis PP, Kitas GD, Viswanathan V, Suri JS.

Comput Biol Med. 2019 Feb;105:125-143. doi: 10.1016/j.compbiomed.2019.01.002. Epub 2019 Jan 8.

PMID:
30641308
13.

Increase in Carotid Temperature Heterogeneity Is Associated With Cardiovascular and Cerebrovascular Events.

Toutouzas K, Benetos G, Oikonomou G, Barampoutis N, Koutagiar I, Galanakos S, Karmpalioti M, Drakopoulou M, Stathogiannis K, Bounas P, Gata V, Antoniadou F, Davlouros P, Alexopoulos D, Hahalis G, Siores E, Sfikakis PP, Tousoulis D.

Circ Cardiovasc Imaging. 2018 Nov;11(11):e008292. doi: 10.1161/CIRCIMAGING.118.008292. No abstract available.

PMID:
30571323
14.

Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.

Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A, Sakkas L, Boumpas D, Voulgari PV, Daoussis D, Thomas K, Georgiopoulos G, Vosvotekas G, Vassilopoulos D, Sfikakis PP.

Arthritis Res Ther. 2018 Dec 4;20(1):267. doi: 10.1186/s13075-018-1771-0.

15.

Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus.

Tentolouris A, Thanopoulou A, Tentolouris N, Eleftheriadou I, Voulgari C, Andrianakos A, Sfikakis PP.

Ann Transl Med. 2018 Oct;6(20):399. doi: 10.21037/atm.2018.09.14.

16.

Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.

Mavrogeni SI, Sfikakis PP, Markousis-Mavrogenis G, Bournia VK, Poulos G, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Boki K, Vartela V, Kolovou G, Theodorakis G, Kitas GD.

Int J Cardiol. 2019 Jun 1;284:105-109. doi: 10.1016/j.ijcard.2018.10.067. Epub 2018 Oct 25.

PMID:
30404725
17.

Nocebos in rheumatology: emerging concepts and their implications for clinical practice.

Kravvariti E, Kitas GD, Mitsikostas DD, Sfikakis PP.

Nat Rev Rheumatol. 2018 Dec;14(12):727-740. doi: 10.1038/s41584-018-0110-9. Review.

PMID:
30361674
18.

Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective Study.

Psichogiou M, Kapelios CJ, Konstantonis G, Argyris A, Nasothimiou E, Papadopoulou M, Kitas G, Papaioannou TG, Daikos GL, Sfikakis PP, Protogerou AD.

Angiology. 2019 May;70(5):448-457. doi: 10.1177/0003319718801093. Epub 2018 Sep 20.

PMID:
30235944
19.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
20.

Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.

Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG.

Rheumatology (Oxford). 2018 Dec 1;57(12):2158-2166. doi: 10.1093/rheumatology/key233.

PMID:
30102390
21.

Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Poulos G, Kolovou G, Theodorakis G, Kitas GD.

Rheumatol Int. 2018 Sep;38(9):1615-1621. doi: 10.1007/s00296-018-4110-5. Epub 2018 Jul 24. Review.

PMID:
30043238
22.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2019 Feb;48(4):752-762. doi: 10.1016/j.semarthrit.2018.05.008. Epub 2018 May 19.

PMID:
29954598
23.

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.

Arida A, Protogerou AD, Kitas GD, Sfikakis PP.

Int J Mol Sci. 2018 Jun 27;19(7). pii: E1890. doi: 10.3390/ijms19071890. Review.

24.

Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort.

Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP, Tektonidou MG.

Autoimmun Rev. 2018 Aug;17(8):816-820. doi: 10.1016/j.autrev.2018.02.008. Epub 2018 Jun 6.

PMID:
29885536
25.

Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus.

Eleftheriadou I, Drosos GC, Tentolouris A, Konstantonis G, Sfikakis PP, Protogerou AD, Tentolouris N.

J Hum Hypertens. 2018 Sep;32(8-9):531-539. doi: 10.1038/s41371-018-0070-1. Epub 2018 May 23.

PMID:
29789692
26.

Microwave Radiometry-Derived Thermal Changes of Small Joints as Additional Potential Biomarker in Rheumatoid Arthritis: A Prospective Pilot Study.

Pentazos G, Laskari K, Prekas K, Raftakis J, Sfikakis PP, Siores E.

J Clin Rheumatol. 2018 Aug;24(5):259-263. doi: 10.1097/RHU.0000000000000719.

PMID:
29652702
27.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
28.

Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.

Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.

Semin Arthritis Rheum. 2018 Dec;48(3):467-474. doi: 10.1016/j.semarthrit.2018.02.014. Epub 2018 Feb 23.

PMID:
29555348
29.

Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.

Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Katsifis G, Markousis-Mavrogenis G, Kolovou G, Kitas GD.

Rheumatol Int. 2018 Jun;38(6):949-958. doi: 10.1007/s00296-018-4004-6. Epub 2018 Mar 7. Review.

PMID:
29516170
30.

Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis.

Dokoupilová E, Aelion J, Takeuchi T, Malavolta N, Sfikakis PP, Wang Y, Rohrer S, Richards HB.

Scand J Rheumatol. 2018 Jul;47(4):276-281. doi: 10.1080/03009742.2017.1390605. Epub 2018 Feb 20.

PMID:
29458278
31.

24-hour aortic blood pressure variability showed a stronger association with carotid damage than 24-hour brachial blood pressure variability: The SAFAR study.

Yu S, Chi C, Protogerou AD, Safar ME, Blacher J, Argyris AA, Nasothimiou EG, Sfikakis PP, Papaioannou TG, Xu H, Zhang Y, Xu Y.

J Clin Hypertens (Greenwich). 2018 Mar;20(3):499-507. doi: 10.1111/jch.13226. Epub 2018 Feb 19.

32.

Mechanisms of pulse pressure amplification dipping pattern during sleep time: the SAFAR study.

Argyris AA, Nasothimiou E, Aissopou E, Papaioannou TG, Zhang Y, Blacher J, Safar ME, Sfikakis PP, Protogerou AD.

J Am Soc Hypertens. 2018 Feb;12(2):117-127. doi: 10.1016/j.jash.2017.12.005. Epub 2017 Dec 14.

PMID:
29287945
33.

Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.

Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG.

Semin Arthritis Rheum. 2018 Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015. Epub 2017 Oct 23.

PMID:
29150207
34.

Non-invasive vascular biomarkers in patients with Behçet's disease: review of the data and future perspectives.

Protogerou AD, Nasothimiou EG, Sfikakis PP, Tzioufas AG.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):100-107. Epub 2017 Oct 6. Review.

35.

High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.

Thomas K, Flouri I, Repa A, Fragiadaki K, Sfikakis PP, Koutsianas C, Kaltsonoudis E, Voulgari PV, Drosos AA, Petrikkou E, Sidiropoulos P, Vassilopoulos D.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):254-262. Epub 2017 Nov 9.

PMID:
29148406
36.

Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases.

Mavrogeni SI, Sfikakis PP, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Dimitroulas T, Kolovou G, Kitas GD.

JACC Cardiovasc Imaging. 2017 Nov;10(11):1387-1396. doi: 10.1016/j.jcmg.2017.08.017. Review.

37.

Accelerated atheromatosis and arteriosclerosis in primary systemic vasculitides: current evidence and future perspectives.

Argyropoulou OD, Protogerou AD, Sfikakis PP.

Curr Opin Rheumatol. 2018 Jan;30(1):36-43. doi: 10.1097/BOR.0000000000000453. Review.

PMID:
29040156
38.

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, van Riel PLCM, Gabriel SE, Matteson EL, Kvien TK, Douglas K, Sandoo A, Arts E, Wållberg-Jonsson S, Innala L, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon C, Ramos VP, Yáñez IC, Sfikakis PP, Zampeli E, Gonzalez-Gay MA, Corrales A, Laar MV, Vonkeman HE, Meek I, Semb AG; A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA).

Ann Rheum Dis. 2018 Jan;77(1):48-54. doi: 10.1136/annrheumdis-2017-211735. Epub 2017 Sep 6.

39.

Severe oesophageal disease and its associations with systemic sclerosis.

Karamanolis GP, Denaxas K, Panopoulos S, Bournia KV, Zorbala A, Kamberoglou D, Schizas D, Ladas SD, Sfikakis PP.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):82-85. Epub 2017 Aug 30.

PMID:
28869413
40.

Erratum to: Assessment of the Validity and Reproducibility of a Novel Standardized Test Meal for the Study of Postprandial Triacylglycerol Concentrations.

Tentolouris N, Kanellos PT, Siami E, Athanasopoulou E, Chaviaras N, Kolovou G, Sfikakis PP, Katsilambros N.

Lipids. 2017 Sep;52(9):801. doi: 10.1007/s11745-017-4284-8. No abstract available.

PMID:
28853039
41.

Brief Report: Drug-Free Long-Term Remission in Severe Behçet's Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment.

Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K, Pentazos G, Laskari K, Tektonidou M, Markomichelakis N.

Arthritis Rheumatol. 2017 Dec;69(12):2380-2385. doi: 10.1002/art.40235. Epub 2017 Nov 8.

42.

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome.

Fragkioudaki S, Nezos A, Souliotis VL, Chatziandreou I, Saetta AA, Drakoulis N, Tzioufas AG, Voulgarelis M, Sfikakis PP, Koutsilieris M, Crow MK, Moutsopoulos HM, Mavragani CP.

Sci Rep. 2017 Aug 4;7(1):7354. doi: 10.1038/s41598-017-07347-w.

43.

Biologic Treatment Options for Retinal Neovascularization in Behçet's Disease.

Markomichelakis NN, Aissopou EK, Maselos S, Tugal-Tutkun I, Sfikakis PP.

Ocul Immunol Inflamm. 2019;27(1):51-57. doi: 10.1080/09273948.2017.1332228. Epub 2017 Jul 12.

PMID:
28700280
44.

Assessment of the Validity and Reproducibility of a Novel Standardized Test Meal for the Study of Postprandial Triacylglycerol Concentrations.

Tentolouris N, Kanellos PT, Siami E, Athanasopoulou E, Chaviaras N, Kolovou G, Sfikakis PP, Katsilambros N.

Lipids. 2017 Aug;52(8):675-686. doi: 10.1007/s11745-017-4275-9. Epub 2017 Jun 26. Erratum in: Lipids. 2017 Aug 29;:.

45.

Association of left ventricular structural and functional abnormalities with aortic and brachial blood pressure variability in hypertensive patients: the SAFAR study.

Chi C, Yu SK, Auckle R, Argyris AA, Nasothimiou E, Tountas C, Aissopou E, Blacher J, Safar ME, Sfikakis PP, Zhang Y, Protogerou AD.

J Hum Hypertens. 2017 Oct;31(10):633-639. doi: 10.1038/jhh.2017.37. Epub 2017 Jun 1.

PMID:
28569260
46.

Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus.

Chorepsima S, Eleftheriadou I, Tentolouris A, Moyssakis I, Protogerou A, Kokkinos A, Sfikakis PP, Tentolouris N.

BMC Endocr Disord. 2017 May 19;17(1):27. doi: 10.1186/s12902-017-0178-2.

47.

Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.

Toutouzas K, Benetos G, Koutagiar I, Barampoutis N, Mitropoulou F, Davlouros P, Sfikakis PP, Alexopoulos D, Stefanadis C, Siores E, Tousoulis D.

Atherosclerosis. 2017 Jul;262:25-30. doi: 10.1016/j.atherosclerosis.2017.04.019. Epub 2017 Apr 23.

PMID:
28482222
48.

Total arterial compliance, estimated by a novel method, is better related to left ventricular mass compared to aortic pulse wave velocity: The SAFAR study.

Papaioannou TG, Protogerou AD, Argyris A, Aissopou E, Georgiopoulos G, Nasothimiou E, Tountas C, Sfikakis PP, Stergiopulos N, Tousoulis D.

Clin Exp Hypertens. 2017;39(3):271-276. doi: 10.1080/10641963.2016.1247165.

PMID:
28448191
49.

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.

Sfikakis PP, Bournia VK, Sidiropoulos P, Boumpas DT, Drosos AA, Kitas GD, Konstantonis G, Liossis SN, Manoussakis MN, Sakkas L, Tektonidou M, Tzioufas AG, Vlachoyiannopoulos PG, Kani C, Paterakis P, Litsa P, Vassilopoulos D.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):579-585. Epub 2017 Mar 3.

PMID:
28281458
50.

Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities.

Arida A, Protogerou AD, Konstantonis G, Fragiadaki K, Kitas GD, Sfikakis PP.

Rheumatology (Oxford). 2017 Jun 1;56(6):934-939. doi: 10.1093/rheumatology/kew506.

PMID:
28160488

Supplemental Content

Loading ...
Support Center